123 related articles for article (PubMed ID: 30636369)
1. Phosphoprotein expression profiles in rat kidney injury: Source for potential mechanistic biomarkers.
Gryshkova V; Cotter M; McGhan P; Obajdin J; Fleurance R; da Costa AN
J Cell Mol Med; 2019 Mar; 23(3):2251-2255. PubMed ID: 30636369
[No Abstract] [Full Text] [Related]
2. Assessment of a Urinary Kidney MicroRNA Panel as Potential Nephron Segment-Specific Biomarkers of Subacute Renal Toxicity in Preclinical Rat Models.
Glineur SF; Hanon E; Dremier S; Snelling S; Berteau C; De Ron P; Nogueira da Costa A
Toxicol Sci; 2018 Dec; 166(2):409-419. PubMed ID: 30169741
[TBL] [Abstract][Full Text] [Related]
3. Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury.
Obajdin J; Cotter M; Snelling S; Dremier S; De Ron P; Fleurance R; Valentin JP; Nogueira da Costa A; Gryshkova V
Toxicol Sci; 2018 Dec; 166(2):441-450. PubMed ID: 30215792
[TBL] [Abstract][Full Text] [Related]
4. The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity.
Tanase DM; Gosav EM; Radu S; Costea CF; Ciocoiu M; Carauleanu A; Lacatusu CM; Maranduca MA; Floria M; Rezus C
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652595
[TBL] [Abstract][Full Text] [Related]
5. Assessment of cisplatin-induced kidney injury using an integrated rodent platform.
Chen Y; Brott D; Luo W; Gangl E; Kamendi H; Barthlow H; Lengel D; Fikes J; Kinter L; Valentin JP; Bialecki R
Toxicol Appl Pharmacol; 2013 May; 268(3):352-61. PubMed ID: 23415679
[TBL] [Abstract][Full Text] [Related]
6. Effect of metformin against cisplatin induced acute renal injury in rats: a biochemical and histoarchitectural evaluation.
Sahu BD; Kuncha M; Putcha UK; Sistla R
Exp Toxicol Pathol; 2013 Sep; 65(6):933-40. PubMed ID: 23395153
[TBL] [Abstract][Full Text] [Related]
7. Effect of glycine on cisplatin nephrotoxicity and heat-shock protein 70 expression in the rat kidney.
Musio F; Carome MA; Bohen EM; Sabnis S; Yuan CM
Ren Fail; 1997 Jan; 19(1):33-46. PubMed ID: 9044450
[TBL] [Abstract][Full Text] [Related]
8. Age-related differences in kidney injury biomarkers induced by cisplatin.
Shin YJ; Kim TH; Won AJ; Jung JY; Kwack SJ; Kacew S; Chung KH; Lee BM; Kim HS
Environ Toxicol Pharmacol; 2014 May; 37(3):1028-39. PubMed ID: 24751685
[TBL] [Abstract][Full Text] [Related]
9. Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat.
Rouse R; Siwy J; Mullen W; Mischak H; Metzger J; Hanig J
PLoS One; 2012; 7(4):e34606. PubMed ID: 22509332
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole protects against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and transporter-mediated cisplatin accumulation in rats and HK-2 cells.
Gao H; Zhang S; Hu T; Qu X; Zhai J; Zhang Y; Tao L; Yin J; Song Y
Chem Biol Interact; 2019 Jan; 297():130-140. PubMed ID: 30452898
[TBL] [Abstract][Full Text] [Related]
11. Protein biomarkers of nephrotoxicity; a review and findings with cyclosporin A, a signal transduction kinase inhibitor and N-phenylanthranilic acid.
Betton GR; Kenne K; Somers R; Marr A
Cancer Biomark; 2005; 1(1):59-67. PubMed ID: 17192032
[TBL] [Abstract][Full Text] [Related]
12. Spatial evaluation of long-term metabolic changes induced by cisplatin nephrotoxicity.
Sahin M; Neumann JM; Riefke B; Bednarz H; Gutberlet K; Giampà M; Niehaus K; Fatangare A
Toxicol Lett; 2020 Nov; 334():36-43. PubMed ID: 32941993
[TBL] [Abstract][Full Text] [Related]
13. Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury.
Wadey RM; Pinches MG; Jones HB; Riccardi D; Price SA
Toxicol Pathol; 2014; 42(3):591-602. PubMed ID: 23823703
[TBL] [Abstract][Full Text] [Related]
14. Study the therapeutic mechanism of Amomum compactum in gentamicin-induced acute kidney injury rat based on a back propagation neural network algorithm.
Wang X; Chen H; Chang C; Jiang M; Wang X; Xu L
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():81-88. PubMed ID: 27978472
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
Portilla D; Schnackenberg L; Beger RD
Semin Nephrol; 2007 Nov; 27(6):609-20. PubMed ID: 18061843
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells.
Sohn SJ; Kim SY; Kim HS; Chun YJ; Han SY; Kim SH; Moon A
Toxicol Lett; 2013 Mar; 217(3):235-42. PubMed ID: 23287709
[TBL] [Abstract][Full Text] [Related]
17. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats.
Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z
Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187
[TBL] [Abstract][Full Text] [Related]
18. A scrutiny of circulating microRNA biomarkers for drug-induced tubular and glomerular injury in rats.
Kagawa T; Zárybnický T; Omi T; Shirai Y; Toyokuni S; Oda S; Yokoi T
Toxicology; 2019 Mar; 415():26-36. PubMed ID: 30682439
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol attenuates acute kidney injury by inhibiting death receptor‑mediated apoptotic pathways in a cisplatin‑induced rat model.
Hao Q; Xiao X; Zhen J; Feng J; Song C; Jiang B; Hu Z
Mol Med Rep; 2016 Oct; 14(4):3683-9. PubMed ID: 27600998
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of urinary biomarkers for nephrotoxicity in cynomolgus monkeys treated with gentamicin, cisplatin, and puromycin aminonucleoside.
Uchino H; Fujishima J; Fukuoka K; Iwakiri T; Kamikuri A; Maeda H; Nakama K
J Toxicol Sci; 2017; 42(5):629-640. PubMed ID: 28904298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
